Use of amprolium for the control of coccidiosis in pheasants.

Amprolium administered in feed during the first 4 weeks of life at a level of 0.0175% protected pheasants against three major pathogenic species of coccidia (Eimeria colchici, E. duodenalis, and E. phasiani) when they were exposed at 2 weeks of age. The difference was significant when mortalities were compared between medicated infected (3%) and unmedicated infected (35%) pheasants. The manufacturer's proposed level (0.0175%) and twice the proposed level (0.0350%) of amprolium had no significant effect on weight gains or mortality in the safety trial. Amprolium residues found in the muscles and livers of pheasants that received either level of amprolium did not exceed the tolerance levels for chickens and turkeys permitted by the U.S. Food and Drug Administration.
AuthorsW H Patton, L D Schwartz, J G Babish, D J Lisk
JournalAvian diseases (Avian Dis) 1984 Jul-Sep Vol. 28 Issue 3 Pg. 693-9 ISSN: 0005-2086 [Print] UNITED STATES
PMID6487190 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Picolines
  • Amprolium
  • Amprolium (therapeutic use)
  • Animals
  • Body Weight
  • Coccidiosis (mortality, prevention & control, veterinary)
  • Eimeria
  • Female
  • Male
  • Picolines
  • Poultry
  • Poultry Diseases (mortality, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: